We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$42.6B
AUM Growth
-$927M
(-2.1%)
Cap. Flow
-$4.42B
Cap. Flow
% of AUM
-10.38%
Top 10 Holdings %
Top 10 Hldgs %
9.02%
Holding
3,518
New
408
Increased
1,022
Reduced
1,392
Closed
532
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$244M |
| 2 |
Pfizer
PFE
|
+$234M |
| 3 |
Nike
NKE
|
+$201M |
| 4 |
Tesla
TSLA
|
+$200M |
| 5 |
S&P Global
SPGI
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$305M |
| 2 |
Advanced Micro Devices
AMD
|
+$241M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$231M |
| 4 |
Merck
MRK
|
+$199M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Healthcare | 11.63% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.76% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Donaldson
DCI
$11.4B
| $6.03M | 0.01% |
80,746
-137,981
| -63% | -$9.39M |
|
852
Cytokinetics
CYTK
$10.4B
| $5.98M | 0.01% |
85,345
-6,495
| -7% | -$502K |
|
853
W&T Offshore
WTI
$518M
| $5.98M | 0.01% |
2,257,894
+825,921
| +58% | +$2.36M |
|
854
Grab
GRAB
$14.9B
| $5.98M | 0.01% |
1,904,972
-1,324,157
| -41% | -$4.25M |
|
|
THS
855
DELISTED
Treehouse Foods
THS
| $5.98M | 0.01% |
153,441
+75,469
| +97% | +$2.99M |
|
856
Ryan Specialty Holdings
RYAN
$11B
| $5.97M | 0.01% |
107,601
+9,722
| +10% | +$465K |
|
857
InterDigital
IDCC
$8.89B
| $5.96M | 0.01% |
55,958
+33,267
| +147% | +$3.52M |
|
858
Franklin Resources
BEN
$17.2B
| $5.96M | 0.01% |
211,852
+121,216
| +134% | +$3.34M |
|
859
Apogee Therapeutics
APGE
$10.2B
| $5.95M | 0.01% |
89,480
+64,441
| +257% | +$2.81M |
|
860
Thomson Reuters
TRI
$44.1B
| $5.93M | 0.01% |
37,492
+25,249
| +206% | +$3.93M |
|
861
Paysafe
PSFE
$375M
| $5.92M | 0.01% |
374,942
-27,303
| -7% | -$382K |
|
862
Weave Communications
WEAV
$423M
| $5.91M | 0.01% |
514,968
+7,216
| +1% | +$86.7K |
|
863
Oaktree Specialty Lending
OCSL
$1.14B
| $5.91M | 0.01% |
300,391
-435,823
| -59% | -$8.8M |
|
864
Silgan Holdings
SLGN
$4.41B
| $5.88M | 0.01% |
121,036
+32,429
| +37% | +$1.44M |
|
865
BrightView Holdings
BV
$1.07B
| $5.87M | 0.01% |
493,376
+44,739
| +10% | +$407K |
|
866
Churchill Downs
CHDN
$6.12B
| $5.86M | 0.01% |
+47,371
| New | +$5.73M |
|
867
Clearwater Paper
CLW
$376M
| $5.83M | 0.01% |
133,340
+39,140
| +42% | +$1.44M |
|
868
MiMedx Group
MDXG
$633M
| $5.8M | 0.01% |
753,740
+133,677
| +22% | +$1.07M |
|
|
INN
869
Summit Hotel Properties
INN
$700M
| $5.77M | 0.01% |
886,458
+147,330
| +20% | +$961K |
|
|
USAR
870
USA Rare Earth Inc
USAR
$4.73B
| $5.76M | 0.01% |
550,000
| – | – |
|
871
National Beverage
FIZZ
$3.01B
| $5.74M | 0.01% |
121,002
+6,684
| +6% | +$327K |
|
872
Chord Energy
CHRD
$7.39B
| $5.73M | 0.01% |
32,171
+22,071
| +219% | +$3.55M |
|
873
PTC Therapeutics
PTCT
$6.12B
| $5.72M | 0.01% |
+196,651
| New | +$5.51M |
|
874
Diamondrock Hospitality Co
DRH
$2.56B
| $5.7M | 0.01% |
593,580
+362,233
| +157% | +$3.39M |
|
875
Scholar Rock
SRRK
$6.44B
| $5.7M | 0.01% |
320,819
+240,862
| +301% | +$3.79M |
|
Similar funds
VAM
Two Sigma Investments's Q1 2024 Portfolio in Review
As of Q1 2024, Two Sigma Investments held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Two Sigma Investments withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Two Sigma Investments opened a new position in Pfizer worth $234M.
- Two Sigma Investments's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
- Two Sigma Investments added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
- Two Sigma Investments's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
- Two Sigma Investments fully exited Rivian in Q1 2024, selling an estimated $158M.
- Two Sigma Investments's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
- Two Sigma Investments opened 408 new positions and closed 532 in Q1 2024.
- Two Sigma Investments's portfolio value fell 2.1% quarter-over-quarter to $42.6B.
Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.